Shweta Mandrekar, Shweta Mandrekar-Colucci
Shweta Mandrekar, Shweta Mandrekar-Colucci
Unknown affiliation
Verified email at case.edu
Title
Cited by
Cited by
Year
ApoE promotes the proteolytic degradation of Aβ
Q Jiang, CYD Lee, S Mandrekar, B Wilkinson, P Cramer, N Zelcer, ...
Neuron 58 (5), 681-693, 2008
8982008
Microglia mediate the clearance of soluble Aβ through fluid phase macropinocytosis
S Mandrekar, Q Jiang, CYD Lee, J Koenigsknecht-Talboo, DM Holtzman, ...
Journal of Neuroscience 29 (13), 4252-4262, 2009
3482009
Microglia and inflammation in Alzheimer's disease
S Mandrekar-Colucci, GE Landreth
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010
3292010
Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease
S Mandrekar-Colucci, JC Karlo, GE Landreth
Journal of Neuroscience 32 (30), 10117-10128, 2012
2932012
PPARγ agonists as therapeutics for the treatment of Alzheimer's disease
G Landreth, Q Jiang, S Mandrekar, M Heneka
Neurotherapeutics 5 (3), 481-489, 2008
2842008
Autonomic dysreflexia causes chronic immune suppression after spinal cord injury
Y Zhang, Z Guan, B Reader, T Shawler, S Mandrekar-Colucci, K Huang, ...
Journal of Neuroscience 33 (32), 12970-12981, 2013
1072013
Nuclear receptors as therapeutic targets for Alzheimer's disease
S Mandrekar-Colucci, GE Landreth
Expert opinion on therapeutic targets 15 (9), 1085-1097, 2011
1002011
PPAR agonists as therapeutics for CNS trauma and neurological diseases
S Mandrekar-Colucci, A Sauerbeck, PG Popovich, DM McTigue
ASN neuro 5 (5), AN20130030, 2013
722013
PPAR agonists as therapeutics for CNS trauma and neurological diseases
S Mandrekar-Colucci, A Sauerbeck, PG Popovich, DM McTigue
ASN neuro 5 (5), AN20130030, 2013
722013
Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments
VP Lemmon, AR Ferguson, PG Popovich, XM Xu, DM Snow, M Igarashi, ...
Journal of neurotrauma 31 (15), 1354-1361, 2014
632014
Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling
JC Gensel, KA Kigerl, SS Mandrekar-Colucci, AD Gaudet, PG Popovich
Cell and tissue research 349 (1), 201-213, 2012
452012
miR-155 deletion in mice overcomes neuron-intrinsic and neuron-extrinsic barriers to spinal cord repair
AD Gaudet, S Mandrekar-Colucci, JCE Hall, DR Sweet, PJ Schmitt, X Xu, ...
Journal of Neuroscience 36 (32), 8516-8532, 2016
422016
Validation of brain angiotensin system blockade as a novel drug target in pharmacological treatment of neuropsychiatric disorders
D Wincewicz, JJ Braszko
Pharmacopsychiatry 50 (06), 233-247, 2017
52017
PPARɣ Activation Rapidly Ameliorates Amyloid Pathology and Restores Cognition in a Mouse Model of Alzheimer’s Disease
SD Mandrekar-Colucci
Case Western Reserve University, 2011
12011
PPAR Agonists as Therapeutics for CNS Trauma and Neurological Diseases
S Mandrekar, AS Colucci, PG Popovich, DM McTigue
2013
PPARγ Agonists for the Treatment of Alzheimer's Disease
Q Jiang, S Mandrekar, G Landreth
Alzheimer's Disease, 81-106, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–16